Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | ACP3 | P15309 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.38 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25787421 | 1.00 | CHRNB2 (0.47) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL26472468 | 0.98 | CHRNB2 (0.45) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL20177076 | 0.98 | CHRNB2 (0.45) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL15780715 | 0.98 | CHRNB2 (0.45) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL19628359 | 0.98 | CHRNB2 (0.45) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL17885889 | 0.98 | CHRNB2 (0.45) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL17692405 | 0.98 | CHRNB2 (0.45) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL13760656 | 0.98 | CHRNB2 (0.43) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL13170726 | 0.96 | ALDH1A1 (0.46) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 | |
| SCHEMBL2704141 | 0.96 | ALDH1A1 (0.46) | CHRNB2CHRNA4ACP3CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8865323-B2 | Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-21 | — | — | US | disclosed |
| US-8865323-B2 | Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-21 | — | — | US | disclosed |
| US-8803134-B2 | Biscarbazole derivatives and organic electroluminescence | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8803134-B2 | Biscarbazole derivatives and organic electroluminescence | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| US-20120223295-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-06 | — | — | US | disclosed |
| US-20120223295-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-06 | — | — | US | disclosed |
| US-20120138912-A1 | BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. | 2012-06-07 | — | — | US | disclosed |
| US-20120138912-A1 | BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120223295-A1 | BISCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE | EED, GABRE, EML4 | CHRNB2 2187/4885CHRNA4 973/4885ACP3 3295/4885 |
| US-20120138912-A1 | BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | UQCRB, OXA1L, HBS1L | CHRNB2 1382/4885CHRNA4 349/4885ACP3 4691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.